Gençoğlu, M. Y.Tuğcu, G. D.Soydaş, S. S. AkyanCinel, G.Emiralioglu, N.Yalçın, E.Kiper, N.Sen, VAltintas, D. UfukCokugras, H.Kilinc, A. AyzitYazan, H.Unal, G.Yilmaz, A., ICaglar, H. T.Damadoglu, E.Irmak, I.Demir, E.Ozturk, G.Bingol, A.Basaran, E.Sapan, N.Aslan, A. T.Asfuroglu, P.Harmanci, K.Kose, M.Hangul, M.Ozdemir, A.Ozcan, G.Gayretli, Z. G.Keskin, O.Yuksel, H.Ozdogan, S.Topal, E.Caltepe, G.Can, D.Ekren, P. KorkmazKilic, M.Eyuboglu, T. SismanlarPekcan, S.Cobanoglu, N.Cakir, E.Ozcelik, U.Dogru, D.2024-12-042024-12-042022-09-040903-1936https://doi.org/10.1183/13993003.congress-2022.4008https://publications.ersnet.org/content/erj/60/suppl66/4008https://hdl.handle.net/11452/48888Bu çalışma, 04-06, Eylül 2022 tarihlerinde Barcelona[İspanya]’da düzenlenen International Congress of the European-Respiratory-Society (ERS) Kongresi‘nde bildiri olarak sunulmuştur.eninfo:eu-repo/semantics/closedAccessRespiratory systemThe efficacy of inhaled hypertonic saline in children with cystic fibrosis who receive daily DNaseMeeting Abstract00089339240542960Supplement 6610.1183/13993003.congress-2022.4008